]>
IRCT20080901001165N39 IRCT 2019-04-24 Bagheiat-allah University of Medical Sciences Effect of curcumine (tumeric) on the inflammatory factors and lipid profile of patients with a history of acute coronary syndrome Evaluation the effect of curcumine on the inflammatory factors and lipid profile of patients with a history of acute coronary syndrome 2018-12-31 anticipated 80 Complete https://irct.ir/trial/32716 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Random assignment to intervention and control groups; randomize using random numbers, Blinding description: The study is done in double blind ways, in which both the researcher and the patient do not know if they received the drug or placebo. But it is explained to the patient who is participating in the study and may receive a drug or placebo. N/A Acute coronary syndrome. Intervention 1: Intervention group: pateints of the treatment group will recieve curcumin capsule (500 mg) every day after breakfast for 30 days. Intervention 2: Control group: pateints of the treatment group will recieve placebo every day after breakfast for 30 days. Yes - There is a plan to make this available What will be shared: Information on the main consequence of the request and after review by the administrators is available for sharing When: Start the access period 6 months after printing the results To whom: Only available to scholars working in academic and academic institutions. Conditions: not known until now Where to obtain: dr yunes panahi in baghiyatollah hospital How to obtain: Submit a written request - Review by the principal responsible for studying and providing information Comments:
public Yunes panahi
Mollasadra ave.
Tehran Iran (Islamic Republic of) 1435916471 +98 21 8248 2503 Yunespanahi@bmsu.ac.ir Bagheiat-allah University of Medical Sciences scientific Yunes Panahi
Mollasadra Ave.
Tehran Iran (Islamic Republic of) 1435916471 +98 21 8248 2503 Yunespanahi@bmsu.ac.ir Bagheiat-allah University of Medical Sciences Iran (Islamic Republic of) All patients with a history of acute coronary syndrome Under the age of 75 y/o 12 years 75 years Both Age over 75 years Use of anticoagulants and warfarin Peptic ulcer History of bleeding, especially gastrointestinal bleeding Child bleeding History of major surgery or recent trauma Severe heart failure I21 ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction Treatment - Drugs Placebo Intervention group: pateints of the treatment group will recieve curcumin capsule (500 mg) every day after breakfast for 30 days Control group: pateints of the treatment group will recieve placebo every day after breakfast for 30 days Lipid profile changes. Timepoint: Baseline, 4 weeks after the start of the intervention. Method of measurement: Lab testing of lipid profile. Decrease of inflammatory factors such as crp. Timepoint: Baseline, 4 weeks after the start of the intervention. Method of measurement: Lab testing of inflammatory factors such as CRP. Bagheiat-allah University of Medical Sciences Approved 2018-10-14 Ethics Committee of Tehran Islamic Azad University of Medical Sciences Yakhchal street, Gholhak, Dr. Shariati ave. Tehran Tehran Iran (Islamic Republic of)